InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
7
T+90 hit rate
23%
T+90 mean return
-23.7%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Benaim Ely. Director active across 1 company, notably NovoCure Ltd. In total, 20 disclosures have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €895k. History available since 10 May 2021. The latest transaction was disclosed on 6 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations20 total
98 shares@ US$62.3050.4% of flowOrdinary SharesSEC:0001645113-23-000012:0
563 shares@ US$71.093.0% of flowOrdinary SharesSEC:0001645113-22-000073:0
437 shares@ US$69.6592.3% of flowOrdinary SharesSEC:0001645113-22-000070:0
222 shares@ US$59.0751.0% of flowOrdinary SharesSEC:0001645113-22-000061:0
2,070 shares@ US$65.1580.0088% mcap10.4% of flowOrdinary SharesSEC:0001645113-22-000046:0
17,371 shares0Ordinary SharesSEC:0001645113-22-000017:0
55 shares@ US$63.8180.0002% mcap0.6% of flowOrdinary SharesSEC:0001645113-22-000006
55 shares@ US$63.8180.0002% mcap0.3% of flowOrdinary SharesSEC:0001645113-22-000006:0
464 shares@ US$150.110.0040% mcap4.8% of flowOrdinary SharesSEC:0001645113-21-000095:0
464 shares@ US$150.114.4% of flowOrdinary SharesSEC:0001645113-21-000095
651 shares@ US$83.300.0031% mcap3.7% of flowOrdinary SharesSEC:0001645113-21-000094:0
651 shares@ US$83.303.5% of flowOrdinary SharesSEC:0001645113-21-000094
90 shares@ US$137.1220.0007% mcap0.8% of flowOrdinary SharesSEC:0001645113-21-000085:0
90 shares@ US$137.1220.8% of flowOrdinary SharesSEC:0001645113-21-000085
1,833 shares@ US$47.565.8% of flowOrdinary SharesSEC:0001645113-21-000069
1,833 shares@ US$47.560.0049% mcap5.8% of flowOrdinary SharesSEC:0001645113-21-000069:0
1,943 shares@ US$180.4823.6% of flowOrdinary SharesSEC:0001645113-21-000068
1,943 shares@ US$180.480.020% mcap23.6% of flowOrdinary SharesSEC:0001645113-21-000068:0
1,833 shares@ US$47.560.0049% mcap5.8% of flowOrdinary SharesSEC:0001645113-21-000067:0
1,833 shares@ US$47.565.8% of flowOrdinary SharesSEC:0001645113-21-000067
20 of 20 declarations
About Benaim Ely
Benaim Ely is an executive at NovoCure Ltd.
